Product Information
DICYCLOMINE 20 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0590 per EA under NDC 72888011901. Its NADAC has been published 175 times since May 31, 2023.
FDA first approved this application on Dec 14, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888011901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICYCLOMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216736FDA Approved
12/14/2022
TE Code
AB
On Market Since
12/14/2022
Pharmacological Classes
Price Statistics
The NADAC for DICYCLOMINE 20 MG TABLET has been published 175 times since May 31, 2023, and over the history we have for it it has declined 62.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0590 per EA |
|---|---|
| All-time high | $0.1556 (Jun 14, 2023) |
| All-time low | $0.0555 (Apr 22, 2026) |
| 52-week high | $0.0674 |
| 52-week low | $0.0555 |
| Median price | $0.0842 |
| Average price | $0.0921 |
| Largest weekly change | +33.0% (Aug 21, 2024) |
| Weeks tracked | 175 |
| Tracking since | May 31, 2023 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dicyclomine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICYCLOMINE 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DICYCLOMINE 20 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0590 per EA (NDC 72888011901), effective Sep 30, 2026.
How has the price of DICYCLOMINE 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for DICYCLOMINE 20 MG TABLET has declined 62.1%. It has been tracked across 175 weekly CMS publications since May 31, 2023.
What are the highest and lowest recorded NADAC prices for DICYCLOMINE 20 MG TABLET?
Since May 31, 2023, the NADAC for DICYCLOMINE 20 MG TABLET has ranged from a low of $0.0555 (Apr 22, 2026) to a high of $0.1556 (Jun 14, 2023), with a median of $0.0842 per EA.
Are there cheaper alternatives to DICYCLOMINE 20 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DICYCLOMINE 20 MG TABLET, is $0.0563 per EA — about 5% below DICYCLOMINE 20 MG TABLET.
Who manufactures DICYCLOMINE 20 MG TABLET?
DICYCLOMINE 20 MG TABLET (NDC 72888011901) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.